Loss of imprinting of igf2 in renal-cell carcinomas

International Journal of Cancer

Volumn 75, Issue 3, 1998, Pages 343-346

  Oda, Hideaki ^a   Kume, Haruki ^a   Shimizu, Yasuhito ^a   Inoue, Tohru ^b   Ishikawa, Takatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER GENETICS; CLINICAL ARTICLE; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENOME IMPRINTING; HETEROZYGOSITY; HUMAN; KIDNEY CARCINOMA; MALE; PRIORITY JOURNAL;

ADULT; AGED; ALLELES; CARCINOMA, RENAL CELL; FEMALE; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MUSCLE PROTEINS; RNA, MESSENGER; RNA, UNTRANSLATED;

EID: 0032579364     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980130)75:3<343::AID-IJC3>3.0.CO;2-2     Document Type: Article

References (32)

1. ANGLARD, P., TORY, K., BRAUCH. H., WEISS, G.H., LATIFF, F., MERINO, M.J., LERMAN, M.I., ZBAR, B. and LINEHAN, W.M., Molecular analysis of genetic changes in the origin and development of renal-cell carcinoma. Cancer Res., 51, 1071-1077 (1991).
2. BARTOLOMEI, M.S., WEBBER, A.L., BRUNKOW, M.E. and TILGHMAN, S.M., Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev., 7, 1663-1673 (1993).
3. FINEBERG, A.P., Genomic imprinting and gene activation in cancer. Nature Genet., 4, 110-113 (1993).
4. GNARRA, J.R. and 23 OTHERS, Mutations of the VHL tumour-suppressor gene in renal carcinoma. Nature Genet., 7, 85-90 (1994).
5. HAO, Y., CRENSHAW, T., MOULTON T., NEWCOMB, E. and TYCKO, B., Tumor-suppressor activity of H19 RNA. Nature (Lond.), 365, 764-767 (1993).
6. HIBI, K., NAKAMURA, H., HIRAI, A., FUJIKAKE, Y., KASAI, Y., AKIYAMA, S., ITO, K. and TAKAGI, H., Loss of H19 imprinting in esophageal cancer. Cancer Res., 56, 480-482 (1996).
7. JINNO, Y., YUN, K., NISHIWAKI, K., KUBOTA, T., OGAWA, O., REEVE, A.E. and NIIKAWA, N., Mosaic and polymorphic imprinting of the WT1 gene in humans. Nature Genet., 10, 318-324 (1995).
8. KONDO, M., SUZUKI, H., UEDA, R., OSADA, H., TAKAGI, K., TAKAHASHI, T. and TAKAHASHI, T., Frequent loss of imprinting of the H19 gene is often associated with its over-expression in human lung cancers. Oncogene, 10, 1193-1198 (1995).
9. LATIF, F. and 32 OTHERS. Identification of the von-Hippel-Lindau-disease tumor-suppressor gene. Science, 260, 1317-1320 (1993).
10. LEIGHMAN, P.A., INGRAM, R.S., EGGENSCHWILER, J., EFSTRATIADIS, A. and TILGHMAN, S.M., Disruption of imprinting caused by deletion of the H19-gene region in mice. Nature (Lond.), 375, 34-39 (1995a).
11. LEIGHTON, P.A., SAAM, J.R., INGRAM, R.S., STEWART, C.L. and TILGHMAN, S.M., An enhancer deletion affects both H19 and Igf2 expression. Genes Dev., 9, 2079-2089 (1995b).
12. LI, X., ADAM, G., CUI, H., SANDSTEDT, B., OHLSSON, R. and EKSTROEM, T.J., Expression, promoter usage and parental imprinting status of insulin-like growth factor II (IGF2) in human hepatoblastoma: uncoupling of ICF2 and H19 imprinting. Oncogene, 11, 221-229 (1995).
13. MORITA, R., ISHIKAWA, J., TSUTSUMI, M., HIKIJI, K., TSUKADA, Y., KAMIDONO, S., MAEDA, S. and NAKAMURA, Y., Allotype of renal-cell carcinoma. Cancer Res., 51, 820-823 (1991).
14. MORRIONE, A., VALENTINIS, B., XU, S., YUMET, G., LOUVI, A., EFSTRATIADIS, A. and BASERGA, R., Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc. nat. Acad. Sci. (Wash.), 94, 3777-3782 (1997).
15. MOSTOFI, F.K., SESTERHEN, I.A. and SOBIN, L.H. (eds.), Histological typing of kidney tumours. International histological classification of tumours, 25, WHO, Geneva (1981).
16. MOTZER, R.J., BANDER, N.H. and NANUS, D.M., Renal-cell carcinoma. New Engl. J. Med., 335, 865-875 (1996).
17. NOONAN, K.E., BECK, C. HOLZMAYER, T.A., CHIN, J.E., WUNDE, J.S., ANDRULIS, I.L., GAZDAR, A.F., WILLMAN, C.L., GRIFFITH, B., VON HOFF, D.D. and RONINSON, I.B., Quantitative analysis of MDR1(multidrug-resistance)-gene expression in human tumors by polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 87, 7160-7164 (1990).
18. ODA, H., NAKATSURU, Y. and ISHIKAWA, T., Mutations of the p53 gene and p53 protein over-expression are associated with sarcomatoid transformation in renal-cell carcinomas. Cancer Res., 55, 658-662 (1995).
19. OGAWA, O., ECCLES, M.R., SZENTO, J., MCNOE, L.A., YUN, K., MAW, M.A., SMITH, P.J. and REEVE, A.E., Relaxation of insulin-like-growth-factor-II-gene imprinting implicated in Wilms' tumour. Nature (Lond.), 362, 749-751 (1993).
20. RAINIER, S., DOBRY, C.J. and FEINBERG, A.P., Loss of imprinting in hepatoblastoma. Cancer Res., 55, 1836-1838 (1995).
21. RAINIER, S., JONSON, L.A., DOBRY, C.J., PING, A.J., GRUNDY, P.E. and FEINBERG, A.P., Relaxation of imprinting genes in human cancer. Nature (Lond.), 362, 747-749 (1993).
22. REITER, R.E., ANGLARD, P., LIU, S., GNARRA, J.R. and LINEHAN, W.M., Chromosome 17p deletions and p53 mutations in renal-cell carcinoma. Cancer Res., 53, 3092-3097 (1993).
23. SHUIN, T., KONDO, K., TORIGOE, S., KlSHIDA, T., KUBOTA, Y., HOSAKA, M., NAGASHIMA, Y., KITAMURA, H., LATIF, F., ZBAR, B., LERMAN, M.I. and YAO, M., Frequent somatic mutations and loss of heterozygosity of the von-Hippel-Lindau tumor-suppressor gene in primary human renal-cell carcinomas. Cancer Res., 54, 2852-2855 (1994).
24. STEENMAN, M.J., RAINIER, S., DOBRY, C.J., GRUNDY, P., HORON, I.L. and FEINBERG, A.P., Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nature Genet., 7, 433-439 (1994).
25. SZABO, P.E. and MANN, J.R., Allele-specific expression and total expression levels of imprinted genes during early mouse development: implications for imprinting mechanisms. Genes Dev., 9, 3097-3108 (1995).
26. TANIGUCHI, T., SULLIVAN, M.J., OGAWA, O. and REEVE, A., Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of ICF2 imprinting and silencing of H19 in Wilms tumor. Proc. nat. Acad. Sci. (Wash.), 92, 2159-2163 (1995).
27. TYCKO, B., Genomic imprinting: mechanism and role in human pathology. Amer. J. Pathol., 144, 431-443 (1994).
28. UICC (INTERNATIONAL UNION AGAINST CANCER), TNM Atlas. Illustrated guide to the TNM/pTNM classification of malignant tumours (3rd ed., 2nd revision). Springer, Berlin (1992).
29. UYENO, S., AOKI, Y., NATA, M., SAGGISAKA, K., KAYAMA, T., YOSHIMOTO, T. and ONO, T., IGF2 but not H19 shows loss of imprinting in human glioma. Cancer Res., 56, 5356-5359 (1996).
30. ZHAN, S., SHAPIRO, D.N. and HELMAN, L.J., Activation of an imprinted allele of the insulin-like-growth-factor-II gene implicated in rhabdomyosarcoma. J. clin. Invest., 94, 445-448 (1994).
31. ZHAN, S., SHAPIRO, D.N. and HELMAN, L.J., Loss of imprinting of IGF2 in Ewing's sarcoma. Oncogene, 11, 2503-2507 (1995).
32. ZHANG, Y. and TYCKO, B., Mono-allelic expression of the human H19 gene. Nature Genet., 1, 40-44 (1992).